Five-Year Outcomes with Anti–Vascular Endothelial Growth Factor Treatment of Neovascular Age-Related Macular Degeneration

Cited by (706)

Items 101–200 of 706

  1. Pharmacological Advances in the Treatment of Age-related Macular Degeneration
    María Gil‐Martínez, Paz Santos-Ramos, Maribel Fernández-Rodríguez, Maximino José Abraldes, María José Rodríguez‐Cid, María Santiago-Varela, Anxo Fernández‐Ferreiro, Francisco Gómez‐Ulla · 2019 · Current Medicinal Chemistry
  2. Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes
    Hansjürgen Agostini, Francis M. Abreu, Caroline R. Baumal, Dolly Shuo-Teh Chang, Karl G. Csaky, Anna Maria Demetriades, Laurent Kodjikian, Jennifer I. Lim, Philippe Margaron, Jordi Monés et al. · 2024 · Graefe s Archive for Clinical and Experimental Ophthalmology
  3. An in vitro Assessment of Thermo-Reversible Gel Formulation Containing Sunitinib Nanoparticles for Neovascular Age-Related Macular Degeneration
    Priyanka Bhatt, Priya Narvekar, Rohan Lalani, Mahavir Bhupal Chougule, Yashwant Vishnupant Pathak, Vijaykumar B. Sutariya · 2019 · AAPS PharmSciTech
  4. Complement Inhibitors in Age-Related Macular Degeneration: A Potential Therapeutic Option
    Shuqi Qin, Ning Dong, Ming Yang, Jialin Wang, Xue Feng, Yanling Wang · 2021 · Journal of Immunology Research
  5. Real-World Data on Faricimab Switching in Treatment-Refractory Neovascular Age-Related Macular Degeneration
    Benjamin Ng, Hema Kolli, Naduviledeth Ajith-Kumar, Matthew Azzopardi, Abison Logeswaran, Julius Buensalido, Bushra Mushtaq, Randhir Chavan, Yu Jeat Chong · 2024 · Life
  6. Pharmacological HIF inhibition prevents retinal neovascularization with improved visual function in a murine oxygen-induced retinopathy model
    Yukihiro Miwa, Yusuke Hoshino, Chiho Shoda, Xiaoyan Jiang, Kazuo Tsubota, Toshihide Kurihara · 2019 · Neurochemistry International
  7. Risk factors for emerging intraocular inflammation after intravitreal brolucizumab injection for age-related macular degeneration
    Ryo Mukai, Hidetaka Matsumoto, Hideo Akiyama · 2021 · PLoS ONE
  8. AAV8-antiVEGFfab Ocular Gene Transfer for Neovascular Age-Related Macular Degeneration
    Liu, Yuanyuan, Fortmann, Seth D., Shen, Jikui, Wielechowski, Erik, Tretiakova, Anna, Yoo, Stephen, Kozarsky, Karen, Wang, Jiangxia, Wilson, James M., Campochiaro, Peter A. · 2018 · Molecular Therapy
  9. Development of Macular Atrophy in Patients with Wet Age-Related Macular Degeneration Receiving Anti-VEGF Treatment
    Alexander J. E. Foss, Tryfon Rotsos, Theo Empeslidis, Victor N. Chong · 2021 · Ophthalmologica
  10. Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results
    Carl D. Regillo, Brian B. Berger, Logan Brooks, W. Lloyd Clark, Robert A. Mittra, Charles C. Wykoff, Natalia F. Callaway, Stephanie DeGraaf, Han Ting Ding, Anne E. Fung et al. · 2023 · Ophthalmology
  11. Long-Term Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration in a Clinical Setting
    Maria I. Eleftheriadou, Clara Vázquez-Alfageme, Maria Cristina Citu, Roxanne Crosby‐Nwaobi, Sobha Sivaprasad, Philip G. Hykin, ROBIN D. HAMILTON, Praveen J. Patel · 2016 · American Journal of Ophthalmology
  12. Long-term outcomes of anti-VEGF treatment of retinal vein occlusion
    Kimberly Spooner, Samantha Fraser‐Bell, Thomas Hong, James Wong, Andrew Chang · 2021 · Eye
  13. Real-World 1-Year Outcomes of Treatment-Intensive Neovascular Age-Related Macular Degeneration Switched to Faricimab
    Sing Yue Sim, Evangelia Chalkiadaki, Georgios Koutsocheras, Luke Nicholson, Sobha Sivaprasad, Praveen J. Patel, Senthil Selvam, Bishwanath Pal, Pearse Andrew Keane, Bhairavi Bhatia et al. · 2024 · Ophthalmology Retina
  14. The Evolution of the Plateau, an Optical Coherence Tomography Signature Seen in Geographic Atrophy
    Anna C. S. Tan, Polina Astroz, Kunal K. Dansingani, Jason S. Slakter, Lawrence A. Yannuzzi, Christine A. Curcio, K. Bailey Freund · 2017 · Investigative Ophthalmology & Visual Science
  15. Economic Value of Anti–Vascular Endothelial Growth Factor Treatment for Patients With Wet Age-Related Macular Degeneration in the United States
    Karen Mulligan, Seth A. Seabury, Pravin U. Dugel, Jill F. Blim, Dana P. Goldman, Mark S. Humayun · 2019 · JAMA Ophthalmology
  16. Switching between ranibizumab and aflibercept for the treatment of neovascular age-related macular degeneration
    Irmela Mantel, Mark C. Gillies, Eric H. Souied · 2018 · Survey of Ophthalmology
  17. CORRELATION OF SUBRETINAL HYPERREFLECTIVE MATERIAL MORPHOLOGY AND VISUAL ACUITY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Jaya B. Kumar, Sandra S. Stinnett, Jung Il Han, Glenn J. Jaffe · 2019 · Retina
  18. Anti-VEGF and Other Novel Therapies for Neovascular Age-Related Macular Degeneration: An Update
    Mariacristina Parravano, Eliana Costanzo, Giulia Scondotto, Gianluca Trifirò, Gianni Virgili · 2021 · BioDrugs
  19. Reduced Vessel Density of the Choriocapillaris during Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration
    Taiichi Hikichi, Mitsuko Agarie · 2019 · Investigative Ophthalmology & Visual Science
  20. Tonabersat Inhibits Connexin43 Hemichannel Opening and Inflammasome Activation in an In Vitro Retinal Epithelial Cell Model of Diabetic Retinopathy
    Heather Lyon, Avik Shome, Ilva D. Rupenthal, Colin Richard Green, Odunayo Omolola Mugisho · 2020 · International Journal of Molecular Sciences
  21. Intravitreal Aflibercept 8 mg in Neovascular Age-Related Macular Degeneration
    Jean-François Korobelnik, Paolo Lanzetta, Sérgio Leal, Frank Gerhard Holz, W. Lloyd Clark, David A. Eichenbaum, Tomohiro Iida, Xiaodong Sun, Alyson J. Berliner, Andrea Schulze et al. · 2025 · Ophthalmology
  22. Re: Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) Research Group, et al.: Five-year outcomes with anti-vascular endothelial growth factor treatment of neovascular age-related macular degeneration: The Comparison of Age-Related Macular Degeneration Treatments Trials (Ophthalmology 2016;123:1751-1761)
    Mark C. Gillies, Vincent Daïen, Vuong Nguyen, Daniel Barthelmes · 2017 · Ophthalmology
  23. Evaluation of a self-imaging SD-OCT system designed for remote home monitoring
    Judy E. Kim, Oren Tomkins‐Netzer, Michael J. Elman, David R. Lally, Michaella Goldstein, Dafna Goldenberg, Shiri Shulman, Gidi Benyamini, Anat Loewenstein · 2022 · BMC Ophthalmology
  24. Zinc deficiency as possible link between immunosenescence and age-related diseases
    Michael Tobias Schulz, Lothar Rink · 2025 · Immunity & Ageing
  25. Controlled release technology for anti-angiogenesis treatment of posterior eye diseases: Current status and challenges
    Chi Ming Laurence Lau, Yu Yu, Ghodsiehsadat Jahanmir, Ying Chau · 2018 · Advanced Drug Delivery Reviews
  26. Molecular Mechanisms Mediating Diabetic Retinal Neurodegeneration: Potential Research Avenues and Therapeutic Targets
    Harshini Chakravarthy, Vasudharani Devanathan · 2018 · Journal of Molecular Neuroscience
  27. Gene Therapy for Non-Hereditary Retinal Disease: Age-Related Macular Degeneration, Diabetic Retinopathy, and Beyond
    Lucas W. Rowe, Thomas A. Ciulla · 2024 · Genes
  28. Targeting Hif1a rescues cone degeneration and prevents subretinal neovascularization in a model of chronic hypoxia
    Maya Barben, Christian Schori, Marijana Samardzija, Christian Grimm · 2018 · Molecular Neurodegeneration
  29. Intravitreal anti-VEGF drug delivery systems for age-related macular degeneration
    Andrea Luaces-Rodríguez, Cristina Mondelo‐García, Irene Zarra‐Ferro, Miguel González‐Barcia, Pablo Aguiar, Anxo Fernández‐Ferreiro, Francisco Javier Otero-Espinar · 2019 · International Journal of Pharmaceutics
  30. TOPOGRAPHIC ANALYSIS OF PHOTORECEPTOR LOSS CORRELATED WITH DISEASE MORPHOLOGY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Sophie Riedl, Lewis Cooney, Christoph Grechenig, Amir Sadeghipour, Eleonore Pablik, John W. Seaman, Sebastian M. Waldstein, Ursula Margarethe Schmidt-Erfurth · 2019 · Retina
  31. Mechanistic Insight into Age-Related Macular Degeneration (AMD): Anatomy, Epidemiology, Genetics, Pathogenesis, Prevention, Implications, and Treatment Strategies to Pace AMD Management
    Mohammad Amin Amini, Ashkan Karbasi, Mohammad Vahabirad, Masoud Khanaghaei, Aida Alizamir · 2023 · Chonnam Medical Journal
  32. VEGF (Vascular Endothelial Growth Factor) Inhibition and Hypertension: Does Microvascular Rarefaction Play a Role?
    Ferdinand A. C. le Noble, Jean‐Jacques Mourad, Bernard I Levy, Harry A.J. Struijker-Boudier · 2023 · Hypertension
  33. Targeted degradation of VEGF with bispecific aptamer-based LYTACs ameliorates pathological retinal angiogenesis
    Ping Zhou, Sai Zhang, Lin Li, Renshuai Zhang, Guizhi Guo, Yufei Zhang, Runa Wang, Miaoyuan Liu, Zhiyi Wang, Huijie Zhao et al. · 2024 · Theranostics
  34. Long-term Safety and Visual Outcome of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration
    Peter K. Kaiser, Michael A. Singer, Michael Tolentino, Robert Vitti, Kristine Erickson, Namrata Saroj, Alyson J. Berliner, Karen W Chu, Xiaoping Zhu, Zinaria Williams Liu et al. · 2017 · Ophthalmology Retina
  35. EXIT STRATEGY IN A TREAT-AND-EXTEND REGIMEN FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
    Petra Arendt, Siqing Yu, Marion Ronit Munk, Andreas Ebneter, Sebastián Wolf, Martin Sebastian Zinkernagel · 2017 · Retina
  36. Outcomes of Suspending VEGF Inhibitors for Neovascular Age-Related Macular Degeneration When Lesions Have Been Inactive for 3 Months
    Vuong Nguyen, Anagha Vaze, Samantha Fraser‐Bell, Jennifer Arnold, Rohan W. Essex, Daniel Barthelmes, Mark C. Gillies · 2019 · Ophthalmology Retina
  37. Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization
    Yingbin Fu, Zhao Zhang, Keith A. Webster, Yannis Mantas Paulus · 2024 · Biomolecules
  38. Two-Year Results of the Phase 3 Randomized Controlled Study of Abicipar in Neovascular Age-Related Macular Degeneration
    Rahul N. Khurana, Derek Y. Kunimoto, Young Hee Yoon, Charles C. Wykoff, Andrew Chang, Raj K. Maturi, Hansjürgen T. Agostini, Eric H. Souied, David Robert Chow, Andrew John Lotery et al. · 2020 · Ophthalmology
  39. Impact of Anti-VEGF Treatment and Patient Characteristics on Vision Outcomes in Neovascular Age-related Macular Degeneration
    Charles C. Wykoff, Vincent Garmo, David C. Tabano, Alicia Menezes, Eunice Kim, Helene B. Fevrier, Andrew LaPrise, Theodore Leng · 2023 · Ophthalmology Science
  40. Estimating Public and Patient Savings From Basic Research—A Study of Optical Coherence Tomography in Managing Antiangiogenic Therapy
    Matthew A. Windsor, Sissi J.J. Sun, Kevin D. Frick, Eric A. Swanson, Philip J. Rosenfeld, David Huang · 2017 · American Journal of Ophthalmology
  41. Insights From Survival Analyses During 12 Years of Anti–Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration
    Dun Jack Fu, Tiarnán D L Keenan, Livia Faes, Ernest Lim, Siegfried K. Wagner, Gabriella Moraes, Josef Christian Huemer, Christoph Kern, Praveen J. Patel, Konstantinos Balaskas et al. · 2020 · JAMA Ophthalmology
  42. As in Real Estate, Location Matters: Cellular Expression of Complement Varies Between Macular and Peripheral Regions of the Retina and Supporting Tissues
    Randy J. Zauhar, Josef Biber, Yassin Jabri, Mijin Kim, Jian Hu, Lew Kaplan, Anna M. Pfaller, Nicole Schäfer, Volker Enzmann, Ursula M. Schlötzer-Schrehardt et al. · 2022 · Frontiers in Immunology
  43. Induced pluripotent stem cell-based therapy for age-related macular degeneration
    Peter Bracha, Nicholas A Moore, Thomas A. Ciulla · 2017 · Expert Opinion on Biological Therapy
  44. miR-185 silencing promotes the progression of atherosclerosis via targeting stromal interaction molecule 1
    Ming Fang, Yanfei Li, Yingbiao Wu, Zhongping Ning, Xuejun Wang, Xinming Li · 2019 · Cell Cycle
  45. Posterior segment drug delivery for the treatment of exudative age-related macular degeneration and diabetic macular oedema
    Chee Wai Wong, Tina Tzee Ling Wong · 2019 · British Journal of Ophthalmology
  46. VEGF Mediates Retinal Müller Cell Viability and Neuroprotection through BDNF in Diabetes
    Yun-Zheng Le, Bei Xu, Ana J. Chucair‐Elliott, Huiru Zhang, Meili Zhu · 2021 · Biomolecules
  47. Optical Coherence Tomography Angiography to Distinguish Changes of Choroidal Neovascularization after Anti-VEGF Therapy: Monthly Loading Dose versus Pro Re Nata Regimen
    Alexandra Mière, Hassiba Oubraham, Francesca Amoroso, Pauline Butori, Polina Astroz, Oudy Semoun, Elsa Bruyère, Alexandre Pedinielli, Manar Addou-Regnard, Camille Jung et al. · 2018 · Journal of Ophthalmology
  48. Safety of 5914 intravitreal ziv-aflibercept injections
    Sumit Randhir Singh, Michael W. Stewart, Goura Chattannavar, Mohammed Ashraf, Ahmed Souka, Mazen ElDardeery, Neeraj Wadhwa, Chintan Sarvaiya, Ahmad M. Mansour, Ameen Marashi et al. · 2018 · British Journal of Ophthalmology
  49. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice
    Koung Li Kim, Wonhee Suh · 2017 · Investigative Ophthalmology & Visual Science
  50. Atrophy in Neovascular Age-Related Macular Degeneration
    Amitha Domalpally, Ronald P. Danis, Ralph Møller Trane, Barbara A. Blodi, Traci E. Clemons, Emily Y. Chew · 2018 · Ophthalmology Retina
  51. The Utah Protocol for Postmortem Eye Phenotyping and Molecular Biochemical Analysis
    Leah A. Owen, Akbar Shakoor, Denise J. Morgan, Andre A. Hejazi, Marshall Wade McEntire, Jared J. Brown, Lindsay A. Farrer, Ivana K. Kim, Albert T. Vitale, Margaret M. DeAngelis · 2019 · Investigative Ophthalmology & Visual Science
  52. Cost-Utility Analysis of VEGF Inhibitors for Treating Neovascular Age-Related Macular Degeneration
    Gary C. Brown, Melissa M. Brown, Sara B. Rapuano, David S. Boyer · 2020 · American Journal of Ophthalmology
  53. Development of Deep Learning Models to Predict Best-Corrected Visual Acuity from Optical Coherence Tomography
    Michael G. Kawczynski, Thomas Bengtsson, Jian Dai, J. Jill Hopkins, Simon S. Gao, Jeffrey Ryuta Willis · 2020 · Translational Vision Science & Technology
  54. LncRNA NEAT1 Sponges MiRNA-148a-3p to Suppress Choroidal Neovascularization and M2 macrophage polarization
    Pengfei Zhang, Bing Lu, Qi Zhang, Fengyuan Xu, Rongrong Zhang, Chen Wang, Yinping Liu, Chenghua Wei, Lixin Mei · 2020 · Molecular Immunology
  55. Baseline Visual Acuity at Wet AMD Diagnosis Predicts Long-Term Vision Outcomes: An Analysis of the IRIS Registry
    Allen C. Ho, David M Kleinman, Flora Lum, Jeffrey S. Heier, Richard L. Lindstrom, Susan Orr, Grace C. Chang, Eleanor L. Smith, John S. Pollack · 2020 · Ophthalmic surgery, lasers & imaging retina
  56. Metformin inhibits ALK1-mediated angiogenesis via activation of AMPK
    Ying Ying, Takashi Ueta, Shanshan Jiang, Hui Lin, Yuanyuan Wang, Demetrios G. Vavvas, Rong Wen, Ye‐Guang Chen, Zhijun Luo · 2017 · Oncotarget
  57. Long-term outcomes of intravitreal anti-VEGF therapies in patients affected by neovascular age-related macular degeneration: a real-life study
    Paolo Corazza, Francesco Maria D’Alterio, Jamil Kabbani, Mostafa Mohamed Ragheb Alam, Stefano Mercuri, Harry O. Orlans, Saad Younis · 2021 · BMC Ophthalmology
  58. Importance of Treatment Duration: Unmasking Barriers and Discovering the Reasons for Undertreatment of Anti-VEGF Agents in Neovascular Age-Related Macular Degeneration
    Bianka Sobolewska, Muhammed Sabsabi, Focke Ziemssen · 2021 · Clinical ophthalmology
  59. Lifetime outcomes of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration
    Finger, Robert P., Puth, Marie-Therese, Schmid, Matthias, Barthelmes, Daniel, Guymer, Robyn H., Gillies, Mark · 2020 · JAMA Ophthalmology
  60. Early-life peripheral infections reprogram retinal microglia and aggravate neovascular age-related macular degeneration in later life
    Masayuki Hata, Maki Hata, Elisabeth M. M. A. Andriessen, Rachel Juneau, Frédérique Pilon, Sergio Crespo‐Garcia, Roberto Diaz-Marin, Vera Guber, François Binet, Frédérik Fournier et al. · 2023 · Journal of Clinical Investigation
  61. Aflibercept for age-related macular degeneration: 4-year outcomes of a ‘treat-and-extend’ regimen with exit-strategy
    Damian Jaggi, Thanoosha Nagamany, Andreas Ebneter, Marion Ronit Munk, Sebastián Wolf, Martin Sebastian Zinkernagel · 2020 · British Journal of Ophthalmology
  62. Protective chromosome 1q32 haplotypes mitigate risk for age-related macular degeneration associated with the CFH-CFHR5 and ARMS2/HTRA1 loci
    Chris M. Pappas, Moussa A. Zouache, Stacie Matthews, Caitlin D. Faust, Jill L. Hageman, Brandi L. Williams, Burt T. Richards, Gregory S. Hageman · 2021 · Human Genomics
  63. Investigational drugs in clinical trials for macular degeneration
    Michael J. Tolentino, Andrew J. Tolentino · 2022 · Expert Opinion on Investigational Drugs
  64. Intravitreal Aflibercept Versus Ranibizumab for Wet Age-Related Macular Degeneration: A Cost-Effectiveness Analysis
    Luis Hernandez, Tereza Lanitis, Clifford Cele, Hector Toro‐Díaz, Andrea Gibson, Andreas Kuznik · 2018 · Journal of Managed Care & Specialty Pharmacy
  65. The Bcl-2/Bcl-xL Inhibitor ABT-263 Attenuates Retinal Degeneration by Selectively Inducing Apoptosis in Senescent Retinal Pigment Epithelial Cells
    Wonseon Ryu, Chul-Woo Park, Junghoon Kim, Hyungwoo Lee, Hyewon Chung · 2023 · Molecules and Cells
  66. Targeting the Angiopoietin/Tie Pathway: Prospects for Treatment of Retinal and Respiratory Disorders
    Racheal Grace Akwii, Constantinos Marios Mikelis · 2021 · Drugs
  67. Side Effects of Brolucizumab
    Tahmineh Motevasseli, S. Saeed Mohammadi, Fatemeh Soghra Abdi, William R. Freeman · 2021 · Journal of Ophthalmic and Vision Research
  68. Exercise alleviates neovascular age-related macular degeneration by inhibiting AIM2 inflammasome in myeloid cells
    Bohao Cui, Xu Guo, Wei Zhou, Xiaodan Zhang, Kai He, Tinghui Bai, Dongxue Lin, Selena Wei-Zhang, Yan Zhao, Shengnan Liu et al. · 2023 · Metabolism
  69. A Proinflammatory Function of Toll-Like Receptor 2 in the Retinal Pigment Epithelium as a Novel Target for Reducing Choroidal Neovascularization in Age-Related Macular Degeneration
    Lili Feng, Meihua Ju, Kei Ying V. Lee, Ashley M. Mackey, Mariasilvia Evangelista, Daiju Iwata, Peter Adamson, Kameran Lashkari, Richard H. Foxton, David T. Shima et al. · 2017 · American Journal Of Pathology
  70. Neovascular age‐related macular degeneration: A review of findings from the real‐world Fight Retinal Blindness! registry
    Vuong Nguyen, Daniel Barthelmes, Mark C. Gillies · 2021 · Clinical and Experimental Ophthalmology
  71. Long-Term Outcomes of Bacillary Layer Detachment in Neovascular Age-Related Macular Degeneration
    Prithvi Ramtohul, Ariane Malclès, Edward Gigon, K. Bailey Freund, Ugo Introini, Francesco Maria Bandello, Maria Vittoria Cicinelli · 2021 · Ophthalmology Retina
  72. Modeling complex age-related eye disease
    Silke Becker, Zia L'Ecuyer, Bryan William Jones, Moussa A. Zouache, Fiona S. McDonnell, Frans Vinberg · 2024 · Progress in Retinal and Eye Research
  73. Fibrotic Changes and Endothelial-to-Mesenchymal Transition Promoted by VEGFR2 Antagonism Alter the Therapeutic Effects of VEGFA Pathway Blockage in a Mouse Model of Choroidal Neovascularization
    Franco Aparecido Rossato, Yu Su, Ashley M. Mackey, Yin‐Shan Ng · 2020 · Cells
  74. Predicting treat-and-extend outcomes and treatment intervals in neovascular age-related macular degeneration from retinal optical coherence tomography using artificial intelligence
    Hrvoje Bogunović, Virgínia Mares, Gregor Sebastian Reiter, Ursula Margarethe Schmidt-Erfurth · 2022 · Frontiers in Medicine
  75. The use of real-world evidence for evaluating anti–vascular endothelial growth factor treatment of neovascular age-related macular degeneration
    James Stephen Talks, Vincent Daïen, Robert Patrick Finger, Bora M. Eldem, Taiji Sakamoto, J.A. Cardillo, Paul Mitchell, Tien Yin Wong, Jean‐François Korobelnik · 2019 · Survey of Ophthalmology
  76. The Fate and Prognostic Implications of Hyperreflective Crystalline Deposits in Nonneovascular Age-Related Macular Degeneration
    Serena Fragiotta, Pedro Fernández-Avellaneda, Mark P. Breazzano, Christine A. Curcio, Belinda C. S. Leong, Kenneth Kato, Lawrence A. Yannuzzi, K. Bailey Freund · 2019 · Investigative Ophthalmology & Visual Science
  77. New Treatment Modalities for Neovascular Age-Related Macular Degeneration
    Patricio Gerardo Schlottmann, Arturo Alezzandrini, Marcelo Zas, Francisco Jose Rodriguez, José D. Luna, Lihteh Wu · 2017 · Asia-Pacific Journal of Ophthalmology
  78. Lactoferrin Has a Therapeutic Effect via HIF Inhibition in a Murine Model of Choroidal Neovascularization
    Mari Ibuki, Chiho Shoda, Yukihiro Miwa, Ayako Ishida, Kazuo Tsubota, Toshihide Kurihara · 2020 · Frontiers in Pharmacology
  79. Recognizing Atrophy and Mixed-Type Neovascularization in Age-Related Macular Degeneration Via Clinicopathologic Correlation
    Ling Chen, Miaoling Li, Jeffrey D. Messinger, Daniela Ferrara, Christine A. Curcio, K. Bailey Freund · 2020 · Translational Vision Science & Technology
  80. Morphological characteristics of eyes with neovascular age-related macular degeneration and good long-term visual outcomes after anti-VEGF therapy
    Mengyuan Fang, Karntida Chanwimol, Jyotsna Maram, Ghazala A. Datoo O’Keefe, Charles C. Wykoff, David Sarraf, A’sha Brown, Shaun I.R. Lampen, Brenda Zhou, Alexander M. Rusakevich et al. · 2021 · British Journal of Ophthalmology
  81. Efficacy, durability, and safety of faricimab in patients from Asian countries with neovascular age-related macular degeneration: 1-Year subgroup analysis of the TENAYA and LUCERNE trials
    Kanji A. Takahashi, Chui Ming Gemmy Cheung, Tomohiro Iida, Timothy Y. Y. Lai, Masahito Ohji, Yasuo Yanagi, Mika Kawano, Shino Ohsawa, Tomoyuki Suzuki, Aachal Kotecha et al. · 2023 · Graefe s Archive for Clinical and Experimental Ophthalmology
  82. Six-year outcomes of antivascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy
    Taiichi Hikichi · 2017 · British Journal of Ophthalmology
  83. Visual Acuity Outcomes after Anti–Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration
    Tiarnán D L Keenan, Susan Vitale, Elvira Agrón, Amitha Domalpally, Andrew N. Antoszyk, Michael J. Elman, Traci E. Clemons, Emily Y. Chew · 2019 · Ophthalmology Retina
  84. Optical Coherence Tomography Angiography Quality Across Three Multicenter Clinical Studies of Diabetic Retinopathy
    Brandon J. Lujan, Claire T. Calhoun, Adam R. Glassman, Joseph M. Googe, Lee M. Jampol, Michele Melia, Deborah K. Schlossman, Jennifer K. Sun, for the DRCR Retina Network · 2021 · Translational Vision Science & Technology
  85. Real-World Performance of a Self-Operated Home Monitoring System for Early Detection of Neovascular Age-Related Macular Degeneration
    Allen C. Ho, Jeffrey S. Heier, Nancy M. Holekamp, Richard A. Garfinkel, Byron S. Ladd, Carl C. Awh, Rishi P. Singh, George E. Sanborn, Jennifer H. Jacobs, Michael J. Elman et al. · 2021 · Journal of Clinical Medicine
  86. VEGF/VEGFR2 blockade does not cause retinal atrophy in AMD-relevant models
    Da Long, Yogita Kanan, Jikui Shen, Sean F. Hackett, Yuanyuan Liu, Zibran Hafiz, Mahmood Khan, Lili Lu, Peter A. Campochiaro · 2018 · JCI Insight
  87. Long-term Visual Outcomes after Release from Protocol in Patients who Participated in the Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) Trial
    Evans, Rebecca N., Reeves, Barnaby C., Phillips, Dawn, Muldrew, Katherine Alyson, Rogers, Chris, Harding, Simon P., Chakravarthy, Usha · 2020 · Ophthalmology
  88. Short-Term Outcomes of 3 Monthly intravitreal Faricimab On Different Subtypes of Neovascular Age-Related Macular Degeneration
    Asako Tanaka, Masayuki Hata, Memiri Tsuchikawa, Naoko Ueda‐Arakawa, Hiroshi Tamura, Manabu Miyata, Ayako Takahashi, Ai Kido, Yuki Muraoka, Masahiro Miyake et al. · 2024 · Clinical ophthalmology
  89. Projection of Long-Term Visual Acuity Outcomes Based on Initial Treatment Response in Neovascular Age-Related Macular Degeneration
    Vuong Nguyen, Vincent Daïen, Robyn H. Guymer, Stephanie H. Young, Alex P. Hunyor, Samantha Fraser‐Bell, Adrian Hunt, Mark C. Gillies, Daniel Barthelmes · 2018 · Ophthalmology
  90. Diabetic Retinopathy Screening Using a Gold Nanoparticle–Based Paper Strip Assay for the At-Home Detection of the Urinary Biomarker 8-Hydroxy-2′-Deoxyguanosine
    Dean P. Hainsworth, Abilash Gangula, Shreya Ghoshdastidar, Raghuraman Kannan, Anandhi Upendran · 2020 · American Journal of Ophthalmology
  91. Evaluation of Long-Lasting Potential of Suprachoroidal Axitinib Suspension Via Ocular and Systemic Disposition in Rabbits
    Viral S. Kansara, Leroy W. Muya, Thomas A. Ciulla · 2021 · Translational Vision Science & Technology
  92. The relationship between pigment epithelial detachment and visual outcome in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy
    Kai Xiong Cheong, Dilraj Singh Grewal, Kelvin Yi Chong Teo, Alfred Tau Liang Gan, Glenn J. Jaffe, Chui Ming Gemmy Cheung · 2020 · Eye
  93. Recurrent Neovascular Age-Related Macular Degeneration after Discontinuation of Vascular Endothelial Growth Factor Inhibitors Managed in a Treat-and-Extend Regimen
    Stamatios Aslanis, Urban Amrén, Charlotte Lindberg, David Lee Epstein · 2021 · Ophthalmology Retina
  94. Heparin-binding VEGFR1 variants as long-acting VEGF inhibitors for treatment of intraocular neovascular disorders
    Hong Xin, Nilima Biswas, Pin Li, Cuiling Zhong, Tamara C. Chan, Eric Nudleman, Napoleone Ferrara · 2021 · Proceedings of the National Academy of Sciences
  95. Subretinal hyperreflective material morphology in neovascular age-related macular degeneration: A case control study
    Divya Alex, Giridhar Anantharaman, Mahesh Gopalakrishnan, Swati Indurkhya, Shivam Madan · 2021 · Indian Journal of Ophthalmology
  96. Understanding patient preferences in anti-VEGF treatment options for age-related macular degeneration
    Semra Özdemir, Eric Andrew Finkelstein, Jia Jia Lee, Issac Horng Khit Too, Kelvin Yi Chong Teo, Anna C. S. Tan, Tien Yin Wong, Chui Ming Gemmy Cheung · 2022 · PLoS ONE
  97. Approved AI-based fluid monitoring to identify morphological and functional treatment outcomes in neovascular age-related macular degeneration in real-world routine
    Virgínia Mares, Ursula Margarethe Schmidt-Erfurth, Oliver Leingang, Philipp Fuchs, Márcio Bittar Nehemy, Hrvoje Bogunović, Daniel Barthelmes, Gregor Sebastian Reiter · 2023 · British Journal of Ophthalmology
  98. Vascular Cell Adhesion Molecule-1 (VCAM-1) contributes to macular fibrosis in neovascular age-related macular degeneration through modulating macrophage functions
    Wen Deng, Caijiao Yi, Wei Pan, Jian Liu, Jinyan Qi, Juan Chen, Zengchao Zhou, Yiqin Duan, Xiangyan Ning, Jun Li et al. · 2023 · Immunity & Ageing
  99. Long-term results of photodynamic therapy or ranibizumab for polypoidal choroidal vasculopathy in LAPTOP study
    Noriko Miyamoto, Michiko Mandai, Akio Oishi, Shunichiro Nakai, Shigeru Honda, Takafumi Hirashima, Hideyasu Oh, Yoshiko Matsumoto, Mamoru Uenishi, Yasuo Kurimoto · 2018 · British Journal of Ophthalmology
  100. Evaluation of a Self-Imaging SD-OCT System for Remote Monitoring of Patients with Neovascular Age Related Macular Degeneration
    Kester Nahen, Gideon Benyamini, Anat Loewenstein · 2020 · Klinische Monatsblätter für Augenheilkunde